Evidence map›Paper›PMID 29225250›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis.

Rieko Nakatani, Takashi Murata, Takeshi Usui, Koki Moriyoshi, Toshiki Komeda, Yuichi Masuda, Maiko Kakita-Kobayashi, Tetsuya Tagami, Shinsaku Imashuku, Shigeo Kono and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Rieko NakataniDepartment of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan.
Takashi MurataDiabetes Center, National Hospital Organization Kyoto Medical Center, Japan.
Takeshi UsuiClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Koki MoriyoshiDepartment of Diagnostic Pathology, National Hospital Organization Kyoto Medical Center, Japan.
Toshiki KomedaDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, Japan.
Yuichi MasudaDiabetes Center, National Hospital Organization Kyoto Medical Center, Japan.
Maiko Kakita-KobayashiDepartment of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan.
Tetsuya TagamiDepartment of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan.
Shinsaku ImashukuDivision of Laboratory Medicine, Uji-Tokushukai Medical Center, Japan.
Shigeo KonoDiabetes Center, National Hospital Organization Kyoto Medical Center, Japan.
Kazunori YamadaDiabetes Center, National Hospital Organization Kyoto Medical Center, Japan.
Akira ShimatsuDepartment of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan.
Kyoto Medical Center · JPSuita Tokushukai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycated hemoglobin (HbA1c) is a widely used marker of glycemic control but can be affected by hemolytic anemia. Glycated albumin (GA) is also affected in patients with liver cirrhosis. We herein report the assessment of glycemic control in a 41-year-old man with dehydrated hereditary stomatocytosis and a PIEZO1 gene mutation complicated by diabetes mellitus and liver cirrhosis due to hemochromatosis. The estimated HbA1c calculated from the average glucose level obtained by continuous glucose monitoring or by self-monitoring of blood glucose was useful for evaluating the glycemic control in this patient, as HbA1c and GA were unreliable due to the coexisting conditions.

Indexed as

AdultAnemia, Hemolytic, CongenitalBiomarkersBlood GlucoseBlood Glucose Self-MonitoringDiabetes ComplicationsGlycated HemoglobinHumansHydrops FetalisLiver CirrhosisMaleBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanaverage glucose levelcontinuous glucose monitoringdehydrated hereditary stomatocytosis with PIEZO1 gene mutationdiabetes mellitusestimated HbA1chemolytic anemia

Identifiers

PMID29225250
PMCPMC5849550
OpenAlexW2772785842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.